Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. OptimizeRx Corp shares valued at $100,220 were purchased by FEBBO WILLIAM J on Dec 12 ’24. At $5.01 per share, FEBBO WILLIAM J acquired 20,000 shares. The insider’s holdings grew to 601,253 shares worth approximately $3.25 million following the completion of this transaction.
As published in a research note from RBC Capital Mkts on January 08, 2025, OptimizeRx Corp [OPRX] has been rated down from an Outperform to a Sector perform and the price target has been revised to $6 from $7. Analysts at Stephens started covering the stock with ‘”an Equal-weight”‘ outlook in a report released in mid December. Earlier on April 04, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for OPRX stock.
Analyzing OPRX Stock Performance
During the last five days, there has been a surge of approximately 11.32%. Over the course of the year, OptimizeRx Corp shares have jumped approximately 11.32%. Shares of the company reached a 52-week high of $6.04 on 01/07/25 and a 52-week low of $4.66 on 01/08/25. A 50-day SMA is recorded $5.19, while a 200-day SMA reached $8.47. Nevertheless, trading volume fell to 0.61 million shares from 0.26 million shares the previous day.
Support And Resistance Levels for OptimizeRx Corp (OPRX)
According to the 24-hour chart, there is a support level at 4.83, which, if violated, would cause prices to drop to 4.25. In the upper region, resistance lies at 5.82. The next price resistance is at 6.23. RSI (Relative Strength Index) is 52.67 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.45, which suggests the price will decrease in the coming days. Percent R is at 33.87%, indicating low price movement. Stochastics %K at selling indicates that the stock is to be held.
